Mirati Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Mirati Therapeutics shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Mirati Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Mirati Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Mirati Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $3.9M | 66k | 58.75 |
| 2023-09-30 | $13M | 298k | 43.56 |
| 2023-06-30 | $11M | 303k | 37.18 |
| 2023-03-31 | $11M | 303k | 37.18 |
| 2022-12-31 | $11M | 240k | 45.31 |
| 2022-09-30 | $14M | 202k | 69.84 |
| 2022-06-30 | $15M | 217k | 67.13 |
| 2022-03-31 | $24M | 288k | 82.22 |
| 2021-12-31 | $79M | 535k | 146.69 |
| 2021-09-30 | $72M | 407k | 176.91 |
| 2021-06-30 | $70M | 431k | 161.53 |
| 2021-03-31 | $80M | 464k | 171.30 |
| 2020-12-31 | $107M | 646k | 166.05 |
| 2020-09-30 | $107M | 646k | 166.05 |
| 2020-06-30 | $69M | 605k | 114.17 |
| 2020-03-31 | $46M | 599k | 76.87 |
| 2019-12-31 | $47M | 365k | 128.86 |
| 2019-09-30 | $18M | 236k | 77.91 |
| 2019-06-30 | $2.3M | 22k | 103.00 |
| 2019-03-31 | $789k | 11k | 73.30 |
| 2018-12-31 | $292k | 6.9k | 42.42 |
| 2018-09-30 | $429k | 9.1k | 47.10 |
| 2018-06-30 | $434k | 8.8k | 49.30 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas